** Shares of NeuBase Therapeutics NBSE.O rise ~22.2% to 87
cents premarket
** Co said late on Friday it has decided to dissolve,
liquidate and distribute to stockholders its available assets
** The board expects to approve a formal plan of dissolution
in the near future - NBSE
** Co said it has been evaluating strategic alternatives
that include an acquisition, merger, business combination,
dissolution or other transaction
** Up to last close, stock was down 85.5% in the last 12
months
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))